Sandoz raises 2026 core EBITDA margin guidance to 23.0%-23.5%
Bitget2026/10/29 07:06- Sandoz narrowed its 2026 net sales growth forecast to 5-6% at constant currencies, from mid-to-high single-digit growth.
- Core EBITDA margin guidance rose to 23-23.5%, versus a previous forecast for roughly 100 basis points of year-over-year expansion.
- Short-term biosimilar supply constraints in Europe and International, alongside tougher German market conditions, weighed on sales expectations.
- Third-quarter sales rose 5% at constant currencies; biosimilar sales increased 17%, supporting a more favorable sales mix.
- The 2028 and 2030 outlooks remain unchanged, including a core EBITDA margin target of 25-27% by 2030.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
